Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF

Author(s):  Allen Loyd V Jr

Issue:  Nov/Dec 2017 - Volume 21, Number 6
View All Articles in Issue

Page(s):  494

Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, hydroxychloroquine sulfate, malaria, antimalarial agent, systemic lupus erythematosus, SLE, rheumatoid arthritis, autoimmune disorders, immune disorders

Related Categories: FORMULATIONS, ALLERGY/IMMUNOLOGY/INFLAMMATION, INFECTIOUS DISEASE, MUSCULOSKELETAL DISORDERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
Nov/Dec 2017
Pg. 494

Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF
Allen Loyd V Jr
Jul/Aug 2020
Pg. 316

Hydroxychloroquine Sulfate 200-mg Capsules
Allen Loyd V Jr
Jan/Feb 2015
Pg. 66

Stability of Extemporaneously Prepared Hydroxychloroquine Sulfate 25-mg/mL Suspensions in Plastic Bottles and Syringes
McHenry Adam R
, Wempe Michael F, Rice Peter J
May/Jun 2017
Pg. 251-254

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 505

Naproxen 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
Jan/Feb 2018
Pg. 54

Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 415

Basics of Compounding for Disorders of the External Ear
Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48

Basics of Compounding for Cough
Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465

Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 47

Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 44

Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 416

Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
May/Jun 2018
Pg. 235

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Neomycin Sulfate 25-mg/mL Oral Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 321

Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 412

Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 136

Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott
, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010
Pg. 182-192

Return to Top